Rivus is focused on advancing cardiometabolic health by developing new oral medicines from its proprietary development platform, including therapies for MASH and obesity
Rivus is focused on advancing cardiometabolic health by developing new oral medicines from its proprietary development platform, including therapies for MASH and obesity.